Federal award
DIAGNOSTIC HYBRIDS INC
0003
Contract
Obligated and Ceiling
- Obligated (net)
- $95,438.63
- Ceiling (potential value, not spending)
- $95,438.63
- Current value
- $95,438.63
- Gross positive obligations
- $173,983.08
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- DIAGNOSTIC HYBRIDS INC · SWUKAJ3C95L1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- QUIDEL CORP · VNAKZRHYAUC7
- Awarding agency
- Department of War · sub-agency 2100 · office W81K02
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- 0003
- Parent vehicle (IDV PIID)
- W81K0213DM001
- Award type code
- C
- Actions
- 3 · Sep 24, 2015 to Sep 17, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History3
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 17, 2020 | FY2020 | 2 | K | −$78,544.45 | — |
| Oct 15, 2015 | FY2016 | 1 | C | $173,983.08 | — |
| Sep 24, 2015 | FY2015 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.